Antitumor agent-21

Modify Date: 2024-01-12 18:41:57

Antitumor agent-21 structure	Common Name	Antitumor agent-21
	CAS Number	1256037-58-7	Molecular Weight	365.250
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₀H₂₅FNO₆P	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Antitumor agent-21

Antitumor agent-21 is an aryl-quinolin derivative, with potential anticancer, anti-inflammatory, anti-proliferative, anti-hormonal effects and inhibition of vasculogenic mimicry[1][2] .

Name	TRX818
Synonym	More Synonyms

Description	Antitumor agent-21 is an aryl-quinolin derivative, with potential anticancer, anti-inflammatory, anti-proliferative, anti-hormonal effects and inhibition of vasculogenic mimicry[1][2] .
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
References	[1]. Sheng-Chu Kuo, et al. Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives. WO2012009519A1. [2]. Novel use of aryl-quinolin derivatives as inhibitors of vasculogenic mimicry. WO2016196742A1.

Description

Antitumor agent-21 is an aryl-quinolin derivative, with potential anticancer, anti-inflammatory, anti-proliferative, anti-hormonal effects and inhibition of vasculogenic mimicry[1][2] .

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> Others >> Others

Research Areas >> Inflammation/Immunology

References

[1]. Sheng-Chu Kuo, et al. Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives. WO2012009519A1.

[2]. Novel use of aryl-quinolin derivatives as inhibitors of vasculogenic mimicry. WO2016196742A1.